These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 9279344

  • 1. [TUT-7 early phase II clinical study for various solid tumors and hematologic malignancies].
    Taguchi T, Wakui A, Niitani H, Furue H, Majima H, Ota K, Ariyoshi H, Hattori T, Sugimachi K, Tsukagoshi S.
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1253-61. PubMed ID: 9279344
    [Abstract] [Full Text] [Related]

  • 2. [Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)].
    Furue H, Machida T, Masaoka T, Ikeda S.
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):67-75. PubMed ID: 9020948
    [Abstract] [Full Text] [Related]

  • 3. [Menogaril (TUT-7) late phase II study for malignant lymphoma, adult T-cell leukemia and lymphoma (ATLL)].
    Taguchi T, Ohta K, Hotta T, Shirakawa S, Masaoka T, Kimura I.
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1263-71. PubMed ID: 9279345
    [Abstract] [Full Text] [Related]

  • 4. [Early phase II clinical trial of amrubicin hydrochloride in patients with malignant lymphoma].
    Masaoka T, Ogawa M, Inoue K, Sanpi K, Kuraishi Y, Toki H, Tamura K, Takagi T, Shibata A, Hirano M, Ezaki K, Shirakawa S, Matsuda T, Kimura I.
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1857-65. PubMed ID: 11729478
    [Abstract] [Full Text] [Related]

  • 5. [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
    Akutsu M, Kano Y, Ogawa M, Miura A, Hirano M, Masaoka T, Tatsumi N.
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1867-76. PubMed ID: 11729479
    [Abstract] [Full Text] [Related]

  • 6. [TUT-7 phase I clinical study. TUT-7 Study Group].
    Taguchi T, Wakui A, Niitani H, Furue H, Majima H, Nakao I, Ota K, Hattori T, Sugimachi K.
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1125-33. PubMed ID: 9239166
    [Abstract] [Full Text] [Related]

  • 7. [Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
    Noda K, Tanaka K, Ozaki M, Hirabayasi K, Hasegawa K, Nishiya I, Yakushiji M, Izumi R, Tomoda Y, Ogita Y, Sugimori H, Yamabe T, Kudo R, Yajima A, Terashima Y, Fujii S, Suzuoki Y, Okada H, Kono I, Ochiai K, Yamamoto T, Ikeda M, Umesaki N, Saito T, Niitani H.
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2061-8. PubMed ID: 9838908
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
    Noda K, Ikeda M, Yakushiji M, Nishimura H, Terashima Y, Sasaki H, Hata T, Kuramoto H, Tanaka K, Takahashi T.
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):885-92. PubMed ID: 1605666
    [Abstract] [Full Text] [Related]

  • 10. [Early phase II study of KRN8602 (MX2), a novel anthracycline derivative for acute leukemia].
    Takemoto Y, Sampi K, Kuraishi Y, Toki H, Tamura K, Ogawa M.
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2243-8. PubMed ID: 9881081
    [Abstract] [Full Text] [Related]

  • 11. [Bropirimine (U-54461S) late phase II clinical study for carcinoma in situ of the bladder. Japan Bropirimine Study Group].
    Akaza H, Shimazaki J, Tashiro K, Kotake T, Okajima E, Kagawa S, Machida T.
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):77-85. PubMed ID: 9020949
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer].
    Koyama H, Adachi I, Tajima T, Kanda K, Yoshida M, Miura S, Nakao K, Kikkawa N, Takai S, Toge T, Tamura K, Inaji H, Shiba E.
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1721-9. PubMed ID: 9757198
    [Abstract] [Full Text] [Related]

  • 15. [A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].
    Kimura K.
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):368-75. PubMed ID: 3947112
    [Abstract] [Full Text] [Related]

  • 16. [Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group].
    Ikeda M, Noda K, Hiura M, Tamaya T, Ozaki M, Hatae M, Ozawa M, Yamabe T, Tanaka K, Izumi R, Okada H, Ogita Y, Hoshiai H.
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2249-57. PubMed ID: 9881082
    [Abstract] [Full Text] [Related]

  • 17. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
    Noda K, Hirabayashi K, Terashima Y, Ozaki M, Yakushiji M, Hatae M, Kanazawa K.
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
    [Abstract] [Full Text] [Related]

  • 18. [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
    Kamiura S, Kobayashi K, Ohira H, Seino H, Hashimoto N, Sawai K, Samejima Y, Saji F.
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):979-86. PubMed ID: 11478148
    [Abstract] [Full Text] [Related]

  • 19. [Phase II study of (2''R)-4'-O-tetrahydropyranyldoxorubicin (THP) in patients with advanced gastrointestinal cancer--a report of the Tohoku THP Study Group].
    Wakui A, Yokoyama M, Yoshida Y, Kikuchi Y, Osawa I, Masamune O, Matsuoka T, Sato S, Kikuchi K, Shoji T.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1032-7. PubMed ID: 3963848
    [Abstract] [Full Text] [Related]

  • 20. [A phase I trial of idarubicin by oral administration].
    Ogawa M, Kimura K, Taguchi T, Wakui A, Hattori M, Shimoyama T, Fujita H.
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1896-900. PubMed ID: 3473981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.